The article News You Might Have Missed: Sep 12th, 2022 was originally published on Microdose. Welcome to the News You Might Have Missed, a weekly roundup...
Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced on Thursday that the previously released positive topline data The post MindMed...
The article MindMed Faces Tough IP Questions (and Publishes Positive Trial Results) was originally published on Microdose. MindMed’s been in the news...
Source: Daniel Patrick Martin / Shutterstock.com MindMed (NASDAQ:MNMD) stock is on the move Wednesday following positive data from a Phase II clinical...
The article The Medicalization of Sacred Plant Medicines was originally published on Microdose. Like many, I’ve watched the recent resurgence of interest...
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD | NEO: MMED), a clinical stage biopharmaceutical company developing novel products to treat brain health disorders,...
Patient participated in ketamine and psilocybin sessions through the Special Access Program from Health Canada The post Field Trip facilitates beneficial...